The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathwayMélissa Carbonneau, Frédérick A. Mallette, Laurence M. Gagné et al.|Nature Communications|2016Cited by 179
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemiaHannah Lawson, Kamil R. Kranc, Lydia M. Wang et al.|Nature Cancer|2024Cited by 40